INS and Impaired glucose tolerance: We aimed to develop a novel blood-based proteomic signature to reliably estimate a direct measure of insulin sensitivity in men and women with normoglycaemia or impaired glucose tolerance using a high-throughput platform able to measure reliably hundreds of low-abundance proteins in plasma.